SARS-CoV-2 vaccination strategies: Should the extended dosing interval strategy be implemented in future pandemics?

• Sandra Valderrama-Beltrán,
• Juliana Cuervo-Rojas,
• Samuel Martinez-Vernaza,
• Carlos A. Alvarez-Moreno,
• Alfonso J. Rodriguez-Morales

Affiliations

Sandra Valderrama-Beltrán

PhD Program in Clinical Epidemiology, Department of Clinical Epidemiology and Biostatistics, Faculty of Medicine, Pontificia Universidad Javeriana, Bogotá, DC, Colombia; Division of Infectious Diseases, Department of Internal Medicine, Faculty of Medicine, Pontificia Universidad Javeriana, Hospital Universitario San Ignacio, Infectious Diseases Research Group, Bogotá, DC, Colombia

Juliana Cuervo-Rojas

Department of Clinical Epidemiology and Biostatistics, Faculty of Medicine, Pontificia Universidad Javeriana, Bogotá, DC, Colombia

Samuel Martinez-Vernaza

Division of Infectious Diseases, Department of Internal Medicine, Faculty of Medicine, Pontificia Universidad Javeriana, Hospital Universitario San Ignacio, Infectious Diseases Research Group, Bogotá, DC, Colombia

Carlos A. Alvarez-Moreno

Department of Internal Medicine, Faculty of Medicine, Universidad Nacional de Colombia, Bogota, DC, 111176, Colombia; Clínica Colsanitas Grupo Keralty, Clínica Universitaria Colombia, Bogota, DC, 111176, Colombia

Alfonso J. Rodriguez-Morales

Corresponding author. Clinical Epidemiology, Universidad Científica del Sur, Lima, Peru.; Clinical Epidemiology and Biostatistics Master Program, Universidad Científica del Sur, Lima, Peru; Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Beirut, Lebanon